{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:56:03Z","timestamp":1791118563886,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.blre.2010.06.004","type":"journal-article","created":{"date-parts":[[2010,7,22]],"date-time":"2010-07-22T08:37:51Z","timestamp":1279787871000},"page":"143-150","source":"Crossref","is-referenced-by-count":214,"title":["Immune hemolytic anemia associated with drug therapy"],"prefix":"10.1016","volume":"24","author":[{"given":"George","family":"Garratty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2010.06.004_bb0005","doi-asserted-by":"crossref","first-page":"619","DOI":"10.7326\/0003-4819-39-3-619","article-title":"Hemolytic anemia secondary to Mesantoin","volume":"39","author":"Snapper","year":"1953","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2010.06.004_bb0010","first-page":"760","article-title":"Studies on the mechanism of a drug-induced hemolytic anemia","volume":"47","author":"Harris","year":"1956","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.blre.2010.06.004_bb0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev.me.18.020167.000415","article-title":"Drug-induced haemolysis","volume":"18","author":"Dausset","year":"1967","journal-title":"Ann Rev Med"},{"key":"10.1016\/j.blre.2010.06.004_bb0020","first-page":"181","article-title":"Immune drug-induced haemolytic anaemias","volume":"6","author":"Worlledge","year":"1969","journal-title":"Semin Hematol"},{"key":"10.1016\/j.blre.2010.06.004_bb0025","series-title":"Acquired immune hemolytic anemias","author":"Petz","year":"1980"},{"key":"10.1016\/j.blre.2010.06.004_bb0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.21307\/immunohematology-2019-1075","article-title":"Current viewpoints on mechanisms causing drug-induced immune hemolytic anemia and\/or positive direct antiglobulin tests","volume":"5","author":"Garratty","year":"1989","journal-title":"Immunohematology"},{"key":"10.1016\/j.blre.2010.06.004_bb0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.21307\/immunohematology-2019-328","article-title":"An update on drug-induced immune hemolytic anemia","volume":"23","author":"Garratty","year":"2007","journal-title":"Immunohematology"},{"key":"10.1016\/j.blre.2010.06.004_bb0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0002-9343(90)90465-P","article-title":"Mortality resulting from blood dyscrasias in the United States, 1984","volume":"88","author":"Hine","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2010.06.004_bb0045","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ajh.20176","article-title":"Proportion of drug-related serious rare blood dyscrasias: estimates from the Berlin case-control surveillance study","volume":"77","author":"Andersohn","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2010.06.004_bb0050","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1182\/blood.V82.9.2714.2714","article-title":"Acute thrombocytopenic purpura in relation to the use of drugs","volume":"82","author":"Kaufman","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.06.004_bb0055","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2165\/00002018-200427150-00007","article-title":"Drug-induced immune thrombocytopenia","volume":"27","author":"van den Bemt","year":"2004","journal-title":"Drug Saf"},{"key":"10.1016\/j.blre.2010.06.004_bb0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/MOH.0b013e3282f15fb9","article-title":"Idiosyncratic drug-induced agranulocytosis or acute neutropenia","volume":"15","author":"Andr\u00e9s","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.blre.2010.06.004_bb0065","series-title":"Immune hemolytic anemias","author":"Petz","year":"2004"},{"key":"10.1016\/j.blre.2010.06.004_bb0070","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.vaccine.2009.10.115","article-title":"Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies","volume":"28","author":"Klein","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.blre.2010.06.004_bb0075","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1084\/jem.67.5.709","article-title":"On cross reactions of immune sera to azoproteins. II. Antigens with azocomponents containing two determinant groups","volume":"67","author":"Landsteiner","year":"1938","journal-title":"J Exp Med"},{"key":"10.1016\/j.blre.2010.06.004_bb0080","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.95.5.473","article-title":"Elicitation of delayed allergic skin reactions with haptens; the dependence of elicitation on hapten combination with protein","volume":"95","author":"Eisen","year":"1952","journal-title":"J Exp Med"},{"key":"10.1016\/j.blre.2010.06.004_bb0085","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4049\/jimmunol.73.5.296","article-title":"Studies of hypersensitivity to low molecular weight substances. III. The 2, 4-dinitrophenyl group as a determinant in the precipitin reaction","volume":"73","author":"Eisen","year":"1954","journal-title":"J Immunol"},{"key":"10.1016\/j.blre.2010.06.004_bb0090","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2141.1984.tb04000.x","article-title":"Ex vivo antigen preparation for the serological detection of drug-dependent antibodies in immune haemolytic anaemias","volume":"58","author":"Salama","year":"1984","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2010.06.004_bb0095","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJM198508223130803","article-title":"The role of metabolite-specific antibodies in nomifensine-dependent immune hemolytic anemia","volume":"313","author":"Salama","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2010.06.004_bb0100","first-page":"30","article-title":"The immunological basis of purpura due to drug hypersensitivity","volume":"55","author":"Ackroyd","year":"1962","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.blre.2010.06.004_bb0105","first-page":"1279","article-title":"Die sedormid-anaphylaxie","volume":"82","author":"Miescher","year":"1952","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1016\/j.blre.2010.06.004_bb0110","series-title":"Blood platelets","first-page":"671","article-title":"Mechanisms of immunogenic platelet damage","author":"Miescher","year":"1961"},{"key":"10.1016\/j.blre.2010.06.004_bb0115","series-title":"Textbook of immunopathology","first-page":"421","article-title":"Drug-induced immunologic blood dyscrasias","author":"Miescher","year":"1976"},{"key":"10.1016\/j.blre.2010.06.004_bb0120","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1084\/jem.107.5.665","article-title":"Immunoreactions involving platelets. I. A steric and kinetic model for formation of complex from a human antibody, quinidine as a haptene, and platelets; and for fixation of complement by the complex","volume":"107","author":"Shulman","year":"1958","journal-title":"J Exp Med"},{"key":"10.1016\/j.blre.2010.06.004_bb0125","first-page":"72","article-title":"Mechanism of blood cell destruction in individuals sensitized to foreign antigens","volume":"76","author":"Shulman","year":"1963","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1016\/j.blre.2010.06.004_bb0130","doi-asserted-by":"crossref","first-page":"506","DOI":"10.7326\/0003-4819-60-3-506","article-title":"A mechanism of cell destruction in individuals sensitized to foreign antigens and its implications in autoimmunity","volume":"60","author":"Shulman","year":"1964","journal-title":"Ann Int Med"},{"key":"10.1016\/j.blre.2010.06.004_bb0135","doi-asserted-by":"crossref","first-page":"176","DOI":"10.7326\/0003-4819-68-1-176","article-title":"Coombs'-test positivity induced by drugs. Mechanisms of immunologic reactions and red cell destruction","volume":"68","author":"Croft","year":"1968","journal-title":"Annals Int Med"},{"key":"10.1016\/j.blre.2010.06.004_bb0140","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0002-9343(75)90606-3","article-title":"Drug-induced immune hemolytic anemia","volume":"58","author":"Garratty","year":"1975","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2010.06.004_bb0145","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1126\/science.127.3306.1118","article-title":"Circulating antibodies directed against penicillin","volume":"127","author":"Ley","year":"1958","journal-title":"Science"},{"key":"10.1016\/j.blre.2010.06.004_bb0150","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0887-7963(93)70145-5","article-title":"Immune cytopenia associated with antibiotics","volume":"VII","author":"Garratty","year":"1993","journal-title":"Trans Med Rev"},{"key":"10.1016\/j.blre.2010.06.004_bb0155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0140-6736(66)92422-6","article-title":"Incidence of a positive direct Coombs test in patients on \u03b1-methyldopa","volume":"2","author":"Carstairs","year":"1966","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2010.06.004_bb0160","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0140-6736(66)92423-8","article-title":"Autoimmune haemolytic anaemia associated with alpha-methyldopa therapy","volume":"2","author":"Worlledge","year":"1966","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2010.06.004_bb0165","doi-asserted-by":"crossref","first-page":"860","DOI":"10.4049\/jimmunol.107.3.860","article-title":"Studies on the immune response to penicillin and cephalothin in humans. II. Immunohematologic reactions to cephalothin administration","volume":"107","author":"Spath","year":"1971","journal-title":"J Immunol"},{"key":"10.1016\/j.blre.2010.06.004_bb0170","series-title":"Clinical aspects of immunology","first-page":"913","article-title":"Immunological mechanisms in drug hypersensitivity","author":"Ackroyd","year":"1975"},{"key":"10.1016\/j.blre.2010.06.004_bb0175","unstructured":"Cronin AE. The immunology of allergic drug reactions. Doctoral thesis. Cambridge, MA: University of Cambridge, 1965."},{"key":"10.1016\/j.blre.2010.06.004_bb0180","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1172\/JCI111691","article-title":"Fab-mediated binding of drug-dependent antibodies to platelets in quinidine- and quinine-induced thrombocytopenia","volume":"75","author":"Christie","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2010.06.004_bb0185","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1172\/JCI112901","article-title":"Binding of quinine- and quinidine-dependent drug antibodies to platelets is mediated by the Fab domain of the immunoglobulin G and is not Fc dependent","volume":"79","author":"Smith","year":"1987","journal-title":"J Clin Invest"},{"issue":"S","key":"10.1016\/j.blre.2010.06.004_bb0190","first-page":"104a","article-title":"A tolmetin-dependent antibody causing severe intravascular hemolysis binds to erythrocyte band 3 and requires only the F(ab)2 domain to react","volume":"66","author":"Jordan","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.06.004_bb0195","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2141.1985.tb04069.x","article-title":"Drug induced red cell autoantibodies co-developed with drug specific antibodies causing haemolytic anaemias","volume":"61","author":"Habibi","year":"1985","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2010.06.004_bb0200","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0887-7963(90)70249-0","article-title":"Drug-induced immune cytopenias: a unifying pathogenetic concept with special emphasis on the role of drug metabolites","volume":"IV","author":"Mueller-Eckhardt","year":"1990","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.blre.2010.06.004_bb0205","series-title":"The specificity of serological reactions","first-page":"185","author":"Landsteiner","year":"1947"},{"key":"10.1016\/j.blre.2010.06.004_bb0210","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4049\/jimmunol.95.3.455","article-title":"The heterogeneity of combining sites of antibodies as determined by specific immunoadsorbents. II. Comparison of elution patterns obtained with anti-p-azobenzoate antibodies by different kinds of immunoadsorbent and eluting hapten","volume":"95","author":"Kitagawa","year":"1965","journal-title":"J Immunol"},{"key":"10.1016\/j.blre.2010.06.004_bb0215","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0140-6736(71)92306-3","article-title":"Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity","volume":"298","author":"Allison","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2010.06.004_bb0220","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1182\/blood.V43.1.85.85","article-title":"Protein-quinone interaction: in vitro induction of indirect antiglobulin reactions with methyldopa","volume":"43","author":"Gottlieb","year":"1974","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.06.004_bb0225","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1056\/NEJM196703232761203","article-title":"The nature of the alphamethyldopa red-cell antibody","volume":"276","author":"LoBuglio","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2010.06.004_bb0230","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJM196706152762420","article-title":"Alpha-methyldopa red-cell antibody: cross-reaction or forbidden clones","volume":"276","author":"Dameshek","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2010.06.004_bb0235","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJM198004103021502","article-title":"Methyldopa inhibition of suppressor-lymphocyte function","volume":"302","author":"Kirtland","year":"1980","journal-title":"N Eng J Med"},{"key":"10.1016\/j.blre.2010.06.004_bb0240","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1365-2141.1993.tb03070.x","article-title":"The effect of methyldopa and procainamide on suppressor cell activity in relation to red cell autoantibody production","volume":"84","author":"Garratty","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2010.06.004_bb0245","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1046\/j.1365-2141.1998.00615.x","article-title":"Positive direct antiglobulin tests and haemolytic anaemia following therapy with beta-lactamase inhibitor containing drugs may be associated with nonimmunologic adsorption of protein onto red blood cells","volume":"100","author":"Garratty","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2010.06.004_bb0250","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.0958-7578.2004.00481.x","article-title":"Tazobactam-induced haemolytic anaemia, possibly caused by non-immunological adsorption of IgG onto patient's red cells","volume":"14","author":"Broadberry","year":"2004","journal-title":"Transfus Med"},{"key":"10.1016\/j.blre.2010.06.004_bb0255","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1423-0410.2003.00323.x","article-title":"Positive direct antiglobulin tests and haemolytic anaemia following therapy with the beta-lactamase inhibitor, tazobactam, may also be associated with non-immunologic adsorption of protein onto red blood cells (letter)","volume":"85","author":"Arndt","year":"2003","journal-title":"Vox Sang"},{"key":"10.1016\/j.blre.2010.06.004_bb0260","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1537-2995.2008.02028.x","article-title":"Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and\/or drug-induced nonimmunologic protein adsorption","volume":"49","author":"Arndt","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2010.06.004_bb0265","first-page":"24S","article-title":"Is severe immune hemolytic anemia, following a single dose of cefotetan, associated with the presence of \u201cnaturally-occurring\u201d anti-cefotetan?","volume":"41","author":"Arndt","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2010.06.004_bb0270","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1046\/j.1537-2995.1999.39111239.x","article-title":"Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and\/or positive direct antiglobulin tests","volume":"39","author":"Arndt","year":"1999","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2010.06.004_bb0275","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1089\/107662903322762815","article-title":"Public health consequences of use of antimicrobial agents in food animals in the United States","volume":"9","author":"Anderson","year":"2003","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.blre.2010.06.004_bb0280","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1542\/peds.2004-1233","article-title":"Nontherapeutic use of antimicrobial agents in animal agriculture: implications for pediatrics","volume":"114","author":"Shea","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.blre.2010.06.004_bb0285","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1517\/14740330802577351","article-title":"Drug-induced immune hemolytic anemia","volume":"8","author":"Salama","year":"2009","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.blre.2010.06.004_bb0290","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1182\/asheducation-2009.1.73","article-title":"Drug-induced immune hemolytic anemia. Hematology","author":"Garratty","year":"2009","journal-title":"Am Soc Hematol Educ Program"},{"key":"10.1016\/j.blre.2010.06.004_bb0295","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1537-2995.2004.03360.x","article-title":"Persistence of cefotetan on red blood cells","volume":"44","author":"Davenport","year":"2004","journal-title":"Transfusion"},{"issue":"S","key":"10.1016\/j.blre.2010.06.004_bb0300","first-page":"13A","article-title":"Successful treatment of life-threatening ceftriaxone-induced hemolysis by plasmapheresis","volume":"49","author":"Doratota","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2010.06.004_bb0305","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1309\/JFJE-VUKN-221T-G6EV","article-title":"Cross-reactivity of cefotetan and ceftiaxone antibodies, associated with hemolytic anemia, with other cephalosporins and penicillin","volume":"118","author":"Arndt","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.blre.2010.06.004_bb0310","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF03256184","article-title":"Cefotetan-induced haemolytic anaemia. A review of 85 cases","volume":"21","author":"Viraraghavan","year":"2002","journal-title":"Adv Drug React Toxicol Rev"},{"key":"10.1016\/j.blre.2010.06.004_bb0315","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0002-9378(99)70443-6","article-title":"Severe immune hemolytic anemia associated with prophylactic use of cefotetan in obstetric and gynecologic procedures","volume":"181","author":"Garratty","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.blre.2010.06.004_bb0320","doi-asserted-by":"crossref","first-page":"27","DOI":"10.21307\/immunohematology-2019-504","article-title":"Practical aspects of investigating drug-induced immune hemolytic anemia due to cefotetan or ceftriaxone \u2013 a case study approach","volume":"18","author":"Arndt","year":"2002","journal-title":"Immunohematology"},{"key":"10.1016\/j.blre.2010.06.004_bb0325","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/INF.0b013e3181629a55","article-title":"Prevalence of ceftriaxone-induced red blood cell antibodies in pediatric patients with sickle cell disease and human immunodeficiency virus infection","volume":"27","author":"Quillen","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.blre.2010.06.004_bb0330","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1111\/j.1537-2995.2008.01852.x","article-title":"Serological studies of piperacillin antibodies","volume":"48","author":"Leger","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2010.06.004_bb0335","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/j.seminoncol.2006.01.011","article-title":"Autoimmune complications of chronic lymphocytic leukemia","volume":"33","author":"Hamblin","year":"2006","journal-title":"Semin Oncol"},{"key":"10.1016\/j.blre.2010.06.004_bb0340","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/10428199309054731","article-title":"Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine","volume":"11","author":"Di Raimondo","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2010.06.004_bb0345","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2141.1995.tb05300.x","article-title":"Fludarabine-related autoimmune haemolyitc anaemia in patients with chronic lymphocytic leukaemia","volume":"91","author":"Myint","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2010.06.004_bb0350","first-page":"113","article-title":"Severe autoimmune hemolytic anemia in eight patients treated with fludarabine","volume":"40","author":"Gonzalez","year":"1998","journal-title":"Hematol Cell Ther"},{"key":"10.1016\/j.blre.2010.06.004_bb0355","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1200\/JCO.1998.16.9.3209","article-title":"Fludarabine and hemolytic anemia in chronic lymphocytic leukemia","volume":"16","author":"Hamblin","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2010.06.004_bb0360","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1182\/blood-2007-07-101303","article-title":"The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia","volume":"111","author":"Dearden","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.06.004_bb0365","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1200\/JCO.1998.16.5.1885","article-title":"Hemolytic anemia after fludarabine therapy for chronic lymphocytic leukemia","volume":"16","author":"Weiss","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2010.06.004_bb0370","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0887-7963(87)70009-1","article-title":"Immunohematologic problems associated with bone marrow transplantation","volume":"1","author":"Petz","year":"1987","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.blre.2010.06.004_bb0375","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1399-3046.2007.00795.x","article-title":"Cold agglutinin syndrome in pediatric liver transplant recipients","volume":"11","author":"Wong","year":"2007","journal-title":"Pediatr Trnasplantation"},{"key":"10.1016\/j.blre.2010.06.004_bb0380","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0041-1345(02)03816-2","article-title":"Severe hemolytic anemia related to production of cold agglutinins following living donor liver transplantation: a case report","volume":"35","author":"Kitamura","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.blre.2010.06.004_bb0385","first-page":"282","article-title":"Tacrolimus-related posttransplant lymphoproliferative disorder presenting as autoimmune hemolytic anemia","volume":"120","author":"DiGuiseppe","year":"1996","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.blre.2010.06.004_bb0390","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3324\/haematol.10733","article-title":"Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenolate, and daclizumab in pancreas transplant recipients","volume":"92","author":"Elimelakh","year":"2007","journal-title":"Haematologica"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X10000275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X10000275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T07:06:35Z","timestamp":1685689595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X10000275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":78,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0268960X10000275"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2010.06.004","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}